Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

You are invited to shape the future of cancer surgical trials at this multidisciplinary NCRI/RCS event. We welcome surgical consultants, trainees, patients, methodologists, trial unit staff and funders to this interactive workshop which aims to create recommendations for future surgical research priorities in surgery for metastatic disease.

Key topics include:

  • Resection of metastatic disease
  • Surgery vs systemic therapy
  • Surgical and other loco-regional treatment of metastatic disease to lung, liver, bone and brain
  • Management of the primary tumour in the presence of metastatic disease
  • Imaging metastatic burden

To register, please visit or email with any queries.

Deadline for registration: Friday 10 February

Attendance is free and refreshments will be provided.

Speakers include:
Mr Robert Ashford, University Hospitals of Leicester
Mr Ravi Barod, Royal Free London
Mr Zaed Hamady, University Hospital Southampton
Dr Maria Hawkins, University of Oxford
Mr Michael Jenkinson, University of Liverpool
Mr Pubudu Pathiraja, Oxford University Hospitals
Mr Michael Shackcloth, Liverpool Heart and Chest Hospital
Dr Nina Tunariu, Royal Marsden Hospital

Co-Chair: Prasanna Sooriakumaran, Consultant Urological Surgeon, University College Hospital London NHS Foundation Trust & Honorary Senior Clinical Researcher, University of Oxford

Co-Chair: Hassan Malik, Consultant Hepatobiliary Surgeon, University Hospital Aintree NHS Trust & Chair of NCRI hepatobiliary sub-group